Purchase Order 36C25521P0656
Award Date
8/26/21
Potential Completion Date
8/25/22
Potential Value
$98K
Federal Agency
Veterans Integrated Service Network 15
Awardee
Sofie CO.
Ultimate Awardee
Sofie Biosciences, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63106, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for prostate cancer detection. The $1,947,056.48 Firm Fixed Price contract was awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the Department of Veterans Affairs (VA). The contract has an ultimate completion date of December 31, 2024. Sofie Biosciences, Inc. is a specialized manufacturer and supplier of...
The Department of Veterans Affairs (VA) awarded a $866,092.80 firm fixed-price purchase order to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for PYLARIFY radiopharmaceuticals. This contract is for the delivery of the PYLARIFY PET imaging agent to support prostate cancer detection programs within the VA's Veterans Integrated Service Network (VISN) 17. Sofie CO. has extensive experience supplying specialized radiopharmaceuticals and related services to various federal agencies, including...
This is a $1,863,815.56 firm fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, for the supply of PYLARIFY (piflufolastat F-18 injection), a radiopharmaceutical used for prostate cancer detection. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025 without any set-aside designation. Sofie is a subsidiary of Sofie Biosciences, Inc. and has extensive experience providing...
This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PET radiopharmaceuticals, which are specialized imaging agents used for medical diagnostics and cancer treatment. The award, valued at $188,258.00, is a delivery order under a larger $5.86 million Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network (VISN) 15 for the...
This federal contract award, valued at $282,073.55, was issued by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of radiopharmaceuticals, which are specialized imaging agents used in medical diagnostics and cancer treatment. The contract is a firm fixed-price purchase order and has a set-aside designation for small businesses. Sofie CO. is an experienced provider of radiopharmaceuticals, pharmaceuticals, and related...
This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $204,375.00 firm-fixed-price purchase order is for the supply of radiopharmaceutical products. The contract does not have a set-aside designation. Sofie CO. is a specialized provider of molecular diagnostics and therapeutics, including radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies such as the VA, Defense Health Agency...
This federal contract award is for the provision of PYLARIFY radiopharmaceuticals and related services to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2). The prime contractor is Sofie CO., a subsidiary of Sofie Biosciences, Inc. that specializes in the development and delivery of molecular diagnostics and therapeutics. The $1,681,341.42 firm-fixed-price delivery order contract supports the VA's medical imaging and cancer treatment programs, enabling the...
The Department of Veterans Affairs Veterans Health Administration awarded a $176,398.24 firm fixed price purchase order to Sofie CO. for the delivery of the radiopharmaceutical PYLARIFY. The contract has a completion date of May 31, 2022 and does not utilize a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics, with extensive experience in PET imaging. The company has received multiple federal...
This is a federal delivery order contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, for the supply of PYLARIFY F-18 isotopes. The contract has a ceiling value of $902,180.00 and runs through August 31, 2029. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly radiopharmaceuticals for medical imaging and cancer treatment. The contract supports the...
The Department of Veterans Affairs Veterans Health Administration awarded a $1.37 million firm fixed price purchase order to Sofie CO., doing business as Sofie, for the delivery of Pylarify radiopharmaceutical isotopes for prostate cancer patients. The contract supports the Special Notice published by VA Network Contracting Office 2 announcing sole source award to Progenics Pharmaceuticals, Inc. through their distributor Sofie. The award aims to provide Pylarify, a prostate-specific membrane...